The Latest Cardiac and Vascular News
DUBLIN–(BUSINESS WIRE)–The “North America Electrocardiograph (ECG) Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Electrocardiograph (ECG) Market is expected to witness market growth of 4.9% CAGR during the forecast period (2017 – 2023). Electrocardiography (ECG) is a non-invasive medical test used in recording electrical activity of the heartbeat over […]
DUBLIN–(BUSINESS WIRE)–The “North America Vascular Graft Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Vascular Graft Market is expected to witness market growth of 5.4% CAGR during the forecast period (2017 – 2023). A vascular graft is a medical device which is used as an artificial blood vessel. These […]
IRVINE, Calif.–(BUSINESS WIRE)–JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Keith D. Dawkins, M.D., as a new JenaValve board member. “As JenaValve advances its clinical development […]
DUBLIN–(BUSINESS WIRE)–The “Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering. “Global TAVI Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market, with focus on the U.S and European markets. The global TAVI market is expected to grow in future due […]
VANCOUVER, March 23, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company“) (NASDAQ, TSX:NVCN) announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum market value requirement set forth in Nasdaq Rules […]
IRVINE, Calif.–(BUSINESS WIRE)– JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Keith D. Dawkins, M.D., as a new JenaValve board member. “As JenaValve advances its clinical development […]
AMSTERDAM, March 23, 2018 /CNW/ – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology has delivered a broad range of health technology solutions to the University of Ottawa Heart Institute (UOHI) – Canada’s largest and foremost heart health centre dedicated to understanding, treating, and preventing heart disease. Today, […]
TUSTIN, Calif.–(BUSINESS WIRE)– A robust suite of quantitative tools to assess the spectrum of liver disease (including Steatosis, Inflammation and Cirrhosis) on Canon Medical Systems U.S.A., Inc.’s premium AplioTM i800 ultrasound system received FDA clearance. The industry’s most comprehensive Liver Analysis Suite is available on the Aplio i800, and may be helpful in the […]
LOS ANGELES–(BUSINESS WIRE)–A scientific presentation of a new vascular embolic device was presented today at the 2018 Society of Interventional Radiology conference in Los Angeles, California – GPX: A New Proprietary In Situ Setting Embolic Agent that Combines the Benefits of Coils, Gel-Beads, and Other Embolics. “GPX is a biocompatible particle embolic loaded in […]
SAN DIEGO–(BUSINESS WIRE)–Unprecedented. That’s what Access Scientific is calling the dramatic results from a leading biofilm laboratory that explain why the company’s POWERWAND™ midlines and extended-dwell catheters consistently report zero associated bloodstream infections (BSIs). Independent, peer-reviewed published studies and scientific posters on the company’s POWERWAND™ catheters – which now tally […]
